• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型 1,8-萘啶衍生物的合成、对胆碱酯酶的抑制活性和神经保护特性。

Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives.

机构信息

Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Instituto Teofilo Hernando, Universidad Autonoma de Madrid, C/Arzobispo Morcillo 4, 28029 Madrid, Spain.

出版信息

J Med Chem. 2010 Jul 22;53(14):5129-43. doi: 10.1021/jm901902w.

DOI:10.1021/jm901902w
PMID:20575555
Abstract

1,8-Naphthyridine derivatives related to 17 (ITH4012), a neuroprotective compound reported by our research group, have been synthesized. In general, they have shown better inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) than most tacrine derivatives previously synthesized in our laboratory. The compounds presented an interesting neuroprotective profile in SH-SY5Y neuroblastoma cells stressed with rotenone/oligomycin A. Moreover, compound 14 (ethyl 5-amino-2-methyl-6,7,8,9-tetrahydrobenzo[b][1,8]naphthyridine-3-carboxylate) also caused protection in cells stressed with okadaic acid (OA) or amyloid beta 1-42 peptide (Abeta(1-42)). Interestingly, compound 14 prevented the OA-induced PP2A inhibition, one of the enzymes implicated in tau dephosphorylation. This compound also exhibited neuroprotection against neurotoxicity elicited by oxygen and glucose deprivation in hippocampal slices. Because these stressors caused neuronal damage related to physiopathological hallmarks found in the brain of Alzheimer's disease (AD) patients, we conclude that compound 14 deserves further in vivo studies in AD models to test its therapeutic potential in this disease.

摘要

我们研究小组报道了一种神经保护化合物 17(ITH4012),与之相关的 1,8-萘啶衍生物已经合成。总的来说,它们对乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BuChE)的抑制作用比我们实验室以前合成的大多数他克林衍生物都要好。这些化合物在受到鱼藤酮/寡霉素 A 应激的 SH-SY5Y 神经母细胞瘤细胞中呈现出有趣的神经保护特征。此外,化合物 14(乙基 5-氨基-2-甲基-6,7,8,9-四氢苯并[b][1,8]萘啶-3-羧酸乙酯)也能对受到岗田酸(OA)或淀粉样β 1-42 肽(Abeta(1-42))应激的细胞产生保护作用。有趣的是,化合物 14 可以防止 OA 诱导的蛋白磷酸酶 2A(PP2A)抑制,PP2A 是一种参与 tau 去磷酸化的酶。该化合物还对海马切片中由缺氧和葡萄糖剥夺引起的神经毒性具有神经保护作用。由于这些应激源引起的神经元损伤与阿尔茨海默病(AD)患者大脑中发现的生理病理特征有关,我们得出结论,化合物 14 值得在 AD 模型中进行进一步的体内研究,以测试其在该疾病中的治疗潜力。

相似文献

1
Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives.新型 1,8-萘啶衍生物的合成、对胆碱酯酶的抑制活性和神经保护特性。
J Med Chem. 2010 Jul 22;53(14):5129-43. doi: 10.1021/jm901902w.
2
Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles.具有胆碱能和神经保护特性的多效药物,用于治疗阿尔茨海默病和神经元血管疾病。I. 简单易得的 2-氨基吡啶和 2-氯吡啶-3,5-二氰基化合物的合成、生物学评价和分子建模。
Bioorg Med Chem. 2010 Aug 15;18(16):5861-72. doi: 10.1016/j.bmc.2010.06.095. Epub 2010 Jul 3.
3
Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles.胆碱能和神经保护药物治疗阿尔茨海默病和神经元血管疾病。二、高取代 2-氨基吡啶-3-氰基的新型他克林类似物的合成、生物评价和分子建模。
Bioorg Med Chem. 2011 Jan 1;19(1):122-33. doi: 10.1016/j.bmc.2010.11.040. Epub 2010 Nov 26.
4
Molecular modelling, synthesis and acetylcholinesterase inhibition of ethyl 5-amino-2-methyl-6,7,8,9-tetrahydrobenzo[b][1,8]naphthyridine-3-carboxylate.分子建模、合成及乙基 5-氨基-2-甲基-6,7,8,9-四氢苯并[b][1,8]萘啶-3-羧酸酯的乙酰胆碱酯酶抑制作用。
Bioorg Med Chem Lett. 2010 May 1;20(9):2950-3. doi: 10.1016/j.bmcl.2010.03.010. Epub 2010 Mar 4.
5
Design, synthesis, and pharmacological profile of novel fused pyrazolo[4,3-d]pyridine and pyrazolo[3,4-b][1,8]naphthyridine isosteres: a new class of potent and selective acetylcholinesterase inhibitors.新型稠合吡唑并[4,3 - d]吡啶和吡唑并[3,4 - b][1,8]萘啶类似物的设计、合成及药理特性:一类新型强效选择性乙酰胆碱酯酶抑制剂
J Med Chem. 2003 Mar 27;46(7):1144-52. doi: 10.1021/jm020391n.
6
ITH4012 (ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a novel acetylcholinesterase inhibitor with "calcium promotor" and neuroprotective properties.ITH4012(5-氨基-6,7,8,9-四氢-2-甲基-4-苯基苯并[1,8]萘啶-3-羧酸乙酯),一种具有“钙促进剂”和神经保护特性的新型乙酰胆碱酯酶抑制剂。
J Pharmacol Exp Ther. 2004 Sep;310(3):987-94. doi: 10.1124/jpet.104.068189. Epub 2004 Apr 26.
7
Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.用于阿尔茨海默病治疗的具有双重抑制乙酰胆碱酯酶和β淀粉样蛋白1-42聚集活性的新型哌啶衍生物的合成、体外测定及分子模拟
Bioorg Med Chem. 2007 Oct 15;15(20):6596-607. doi: 10.1016/j.bmc.2007.07.003. Epub 2007 Jul 25.
8
Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties.他克林 - 褪黑素杂合物作为用于阿尔茨海默病的多功能药物,具有胆碱能、抗氧化和神经保护特性。
ChemMedChem. 2009 May;4(5):828-41. doi: 10.1002/cmdc.200800414.
9
Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease.用于治疗阿尔茨海默病的多功能谷氨酸衍生物的神经保护和胆碱能特性
J Med Chem. 2009 Nov 26;52(22):7249-57. doi: 10.1021/jm900628z.
10
Benzofuran-based hybrid compounds for the inhibition of cholinesterase activity, beta amyloid aggregation, and abeta neurotoxicity.用于抑制胆碱酯酶活性、β-淀粉样蛋白聚集和β-淀粉样蛋白神经毒性的基于苯并呋喃的杂化化合物。
J Med Chem. 2008 May 22;51(10):2883-6. doi: 10.1021/jm8002747. Epub 2008 Apr 18.

引用本文的文献

1
Promising Molecular Targets in Pharmacological Therapy for Neuronal Damage in Brain Injury.脑损伤中神经元损伤药物治疗中有前景的分子靶点
Antioxidants (Basel). 2023 Jan 3;12(1):118. doi: 10.3390/antiox12010118.
2
A Review on Metal-Organic Frameworks as Congenial Heterogeneous Catalysts for Potential Organic Transformations.金属有机框架作为潜在有机转化的理想多相催化剂的综述
Front Chem. 2021 Dec 17;9:747615. doi: 10.3389/fchem.2021.747615. eCollection 2021.
3
Gram-Scale Synthesis of 1,8-Naphthyridines in Water: The Friedlander Reaction Revisited.
水中1,8-萘啶的克级合成:对Friedlander反应的重新审视
ACS Omega. 2021 Jul 12;6(29):19304-19313. doi: 10.1021/acsomega.1c02798. eCollection 2021 Jul 27.
4
Protein Phosphatase 2A as a Drug Target in the Treatment of Cancer and Alzheimer's Disease.蛋白磷酸酶 2A 作为治疗癌症和阿尔茨海默病的药物靶点。
Curr Med Sci. 2020 Feb;40(1):1-8. doi: 10.1007/s11596-020-2140-1. Epub 2020 Mar 13.
5
QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer's Disease Therapy.喹喔啉他克林 QT78,一种胆碱酯酶抑制剂,有望成为治疗老年痴呆症的配体。
Molecules. 2019 Apr 17;24(8):1503. doi: 10.3390/molecules24081503.
6
The Potential Use of Plant Natural Products and Plant Extracts with Antioxidant Properties for the Prevention/Treatment of Neurodegenerative Diseases: In Vitro, In Vivo and Clinical Trials.植物天然产物和具有抗氧化特性的植物提取物在预防/治疗神经退行性疾病中的潜在用途:体外、体内和临床试验。
Molecules. 2018 Dec 11;23(12):3283. doi: 10.3390/molecules23123283.
7
Protein phosphorylation in neurodegeneration: friend or foe?神经退行性变中的蛋白质磷酸化:是友还是敌?
Front Mol Neurosci. 2014 May 13;7:42. doi: 10.3389/fnmol.2014.00042. eCollection 2014.
8
Synthesis and functional survey of new Tacrine analogs modified with nitroxides or their precursors.用氮氧化物或其前体修饰的新型他克林类似物的合成与功能研究。
Eur J Med Chem. 2014 Apr 22;77:343-50. doi: 10.1016/j.ejmech.2014.03.026. Epub 2014 Mar 12.
9
PP2A ligand ITH12246 protects against memory impairment and focal cerebral ischemia in mice.PP2A 配体 ITH12246 可预防小鼠的记忆损伤和局灶性脑缺血。
ACS Chem Neurosci. 2013 Sep 18;4(9):1267-77. doi: 10.1021/cn400050p. Epub 2013 Jun 13.
10
Benzothiazepine CGP37157 and its isosteric 2'-methyl analogue provide neuroprotection and block cell calcium entry.苯并噻氮䓬 CGP37157 及其等排 2'-甲基类似物具有神经保护作用,并阻断细胞钙内流。
ACS Chem Neurosci. 2012 Jul 18;3(7):519-29. doi: 10.1021/cn300009e. Epub 2012 Mar 26.